Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 30 min ago
Peer-reviewedCC BY 4.0Scientific Reports

[18F]FDG brain PET-MR versus PET/CT in a clinical cohort: intra-subject quantitative comparisons

Abstract

There is limited evidence on the advantages of brain 2-deoxy-2-[ ¹⁸ F]fluoroglucose (FDG) positron emission tomography (PET) with simultaneous magnetic resonance imaging (PET-MR) over PET with computed tomography (PET/CT). We quantitatively compared brain FDG PET/CT and PET-MR images from a large clinical cohort. Participants with refractory epilepsy or cognitive problems underwent PET/CT at approximately 30 min post-injection, followed by PET-MR at approximately 100 min. Standardized uptake values (SUVs) were extracted in anatomical regions using a multi-atlas method, and voxel-wise comparisons were performed with statistical parametric mapping. Fifty-five image pairs passed quality control. Within-subject correlations between modalities were very high (0.96, range 0.84–0.99); within-region, across-participant correlations were 0.82 (0.72–0.90). PET-MR SUVs were on average 20% higher than PET/CT, more so for higher-uptake regions. Voxel-wise, PET-MR showed relatively higher uptake in visual and auditory cortices, lower uptake in medial frontal and anteromesial temporal cortices, and better grey-white matter contrast. We found a very close correspondence between the two modalities with their respective attenuation correction methods and sensory activation between scans; the different uptake times explain differences in absolute SUV levels and grey-white matter contrast. With awareness of these differences, brain PET-MR can be used clinically.

Related

  1. Rapid screening of urinary tract infections: quantitative flow cytometry versus dipstick testing in a hospital cohort
    B. Dirk, T. Hwandih, M. Holz +2
    InfectionPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMC
  2. Short-term clinical outcomes of nasoduodenal tube versus feeding jejunostomy after minimally invasive esophagectomy: a retrospective cohort study with exploratory microbiome analysis
    Qi-Yue Ge, Chang-Yong Wang, Chao Zheng +7
    Journal of thoracic diseasePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Clinical profile, risk factors and in-hospital outcomes of ST-segment elevation myocardial infarction in young versus older adults: a 5-year retrospective cohort study at a tertiary care centre in Riyadh, Saudi Arabia.
    Faisal Alhusain, Fatimah Alsumari, Renad Almasari +5
    BMJ openPeer-reviewedCC BY-NCFull textCardiovascular medicineEurope PMCCrossref
  4. Observation versus maintenance immunotherapy after PD-1-induced clinical complete response in dMMR/MSI-H colorectal cancer managed non-operatively: a multicenter cohort study.
    Xiaohang Gao, Qiaoxuan Wang, Zitong Zhang +15
    Journal for immunotherapy of cancerPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  5. Inter-subject receive-template substitution for quantitative brain water content mapping at 3 T: a leave-one-out evaluation
    Zaheer Abbas, Faizan Ullah, Sergo Gegechkori +2
    Frontiers in NeurosciencePeer-reviewedCC BY 4.0Full textMedical imaging & radiologyCrossrefEurope PMCPMCEurope PMC
BibTeX
@article{martinez202618ffdg,
  title = {{[18F]FDG brain PET-MR versus PET/CT in a clinical cohort: intra-subject quantitative comparisons}},
  author = {Arick Sagel Martinez and Anthime Flaus and Rolf A. Heckemann and Joel Dunn and Sufian Al-Ethawi and Sami Jeljeli and Colm J. McGinnity and Alexander Hammers},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-72030-y},
  url = {https://www.nature.com/articles/s41598-026-72030-y},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - [18F]FDG brain PET-MR versus PET/CT in a clinical cohort: intra-subject quantitative comparisons
AU  - Arick Sagel Martinez
AU  - Anthime Flaus
AU  - Rolf A. Heckemann
AU  - Joel Dunn
AU  - Sufian Al-Ethawi
AU  - Sami Jeljeli
AU  - Colm J. McGinnity
AU  - Alexander Hammers
PY  - 2026
DA  - 2026/10/27
JO  - Scientific Reports
DO  - 10.1038/s41598-026-72030-y
UR  - https://www.nature.com/articles/s41598-026-72030-y
AB  - There is limited evidence on the advantages of brain 2-deoxy-2-[ ¹⁸ F]fluoroglucose (FDG) positron emission tomography (PET) with simultaneous magnetic resonance imaging (PET-MR) over PET with computed tomography (PET/CT). We quantitatively compared brain FDG PET/CT and PET-MR images from a large clinical cohort. Participants with refractory epilepsy or cognitive problems underwent PET/CT at approximately 30 min post-injection, followed by PET-MR at approximately 100 min. Standardized uptake values (SUVs) were extracted in anatomical regions using a multi-atlas method, and voxel-wise comparisons were performed with statistical parametric mapping. Fifty-five image pairs passed quality control. Within-subject correlations between modalities were very high (0.96, range 0.84–0.99); within-region, across-participant correlations were 0.82 (0.72–0.90). PET-MR SUVs were on average 20% higher than PET/CT, more so for higher-uptake regions. Voxel-wise, PET-MR showed relatively higher uptake in visual and auditory cortices, lower uptake in medial frontal and anteromesial temporal cortices, and better grey-white matter contrast. We found a very close correspondence between the two modalities with their respective attenuation correction methods and sensory activation between scans; the different uptake times explain differences in absolute SUV levels and grey-white matter contrast. With awareness of these differences, brain PET-MR can be used clinically.
SN  - 2045-2322
ER  -